Nuveen »

Century Therapeutics shares owned by Nuveen

Quarter-by-quarter ownership of Century Therapeutics (IPSC) shares owned by Nuveen from 13F filings

Historical chart of Nuveen investment in Century Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Century Therapeutics held by Nuveen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Century Therapeutics by Nuveen

Quarter filed Position value Share count Share price at filing
2026-06-30 $401k 164k 2.45
2025-03-31 $75k 157k 0.48

More positions owned by Nuveen

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
Applied Materials (AMAT)
Lam Research Corp Com New (LRCX)
Advanced Micro Devices (AMD)

View all positions for Nuveen

Top funds holding Century Therapeutics

RA Capital Management
TCG Crossover Management
Versant Venture Management
Deep Track Capital
VR Adviser
Rtw Investments
Commodore Capital
BlackRock
Vanguard Capital Management
Balyasny Asset Management
Point72 Asset Management
Seven Fleet Capital Management
Woodline Partners
Millennium Management
Trails Edge Capital Partners

View all funds holding Century Therapeutics